Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Joseph Mierski"'
Autor:
Claudia Mae Velasco, Kevin Rakszawski, Joseph Cioccio, Myles Nickolich, Seema Naik, Hong Zheng, Baldeep Wirk, W Christopher Ehmann, David F Claxton, Witold Rybka, Raymond Hohl, Joseph Mierski, Brooke Silar, Caitlin Vajdic, Robert Greiner, Dr. Valerie I. Brown, Hiroko Shike, Shin Mineishi, Kentaro Minagawa
Publikováno v:
Transplantation and Cellular Therapy. 29:S419-S420
Autor:
Neal Shah, Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Baldeep Wirk, Witold Rybka, Christopher Ehmann, Brook Silar, Caitlin Vajdic, Joseph Mierski, Shouhao Zhou, Hiroko Shike, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Shin Mineishi, Kentaro Minagawa, Leonard Tuanquin
Publikováno v:
Leukemia research. 123
Autor:
Emma Zulch, Nicholas Streck, Joseph Matthew Cioccio, Kevin L Rakszawski, Myles Nickolich, W. Christopher Ehmann, Baldeep Wirk, Seema G Naik, Witold B. Rybka, Hong Zheng, Jeffrey M Sivik, Cory Hale, Joseph Mierski, Brooke Silar, Robert Greiner, Valerie Brown, Hiroko Shike, David F. Claxton, David Craft, April Bobenchik, Shin Mineishi, Catharine I Paules, Kentaro Minagawa
Publikováno v:
Blood. 140:7589-7590
Autor:
Emma Zulch, Joseph Cioccio, Kevin Rakszawski, Myles Nickolich, W Christopher Ehmann, Baldeep Wirk, Seema Naik, Witold Rybka, Hong Zheng, Hiroko Shike, Jeffery Sivik, Joseph Mierski, Brooke Silar, Robert Greiner, Valerie Brown, Leonard Tuanquin, David F Claxton, Shin Mineishi, Kentaro Minagawa
Publikováno v:
Transplantation and Cellular Therapy. 28:S147-S148
Autor:
Shin Mineishi, Christopher Ehmann, David F. Claxton, Valerie I. Brown, Neal Shah, Witold B. Rybka, Joseph Mierski, Gina Mackey, Hong Zheng, Myles Nickolich, Seema Naik, Kentaro Minagawa, Baldeep Wirk, Robert J. Greiner, Kevin Rakszawski, Brooke Silar
Publikováno v:
Annals of hematology. 100(10)
Acute myeloid leukemia (AML) relapse after allogeneic stem cell transplant (alloSCT) remains a major therapeutic challenge. While patients with longer remission after initial alloSCT are recommended to receive cell therapy (CT) such as 2ndalloSCT or
Autor:
Shin Mineishi, Brooke Silar, Seema Naik, Joseph Mierski, Witold B. Rybka, W. Christopher Ehmann, Ruoheng Zhang, Hiroko Shike, Hong Zheng, Baldeep Wirk, Shouhao Zhou, David F. Claxton, Jason Liao, Valerie I. Brown, Kevin Rakszawski, Kentaro Minagawa, Gina Mackey, Robert J. Greiner, Myles Nickolich
Publikováno v:
Blood. 138:1792-1792
Recipient chimerism increase has been used to predict leukemia relapse in post-hematopoietic cell transplant (HCT) patients with conventional GVHD prophylaxis. However, the value of recipient chimerism increase in patients with post-transplant cyclop
Autor:
Baldeep Wirk, Brooke Silar, Shin Mineishi, David F. Claxton, Kentaro Minagawa, Hong Zheng, Witold B. Rybka, Robert J. Greiner, Neal Shah, Joseph Mierski, Kevin Rakszawski, Seema Naik, Valerie I. Brown, W. Christopher Ehmann, Myles Nickolich, Gina Mackey
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S99-S100
Background Acute myeloid leukemia (AML) relapse after allogeneic stem cell transplant (allo SCT) remains a major therapeutic challenge. While patients with longer remission after initial allo SCT are recommended to receive either 2nd allo SCT or dono
Autor:
Witold B. Rybka, W. Christopher Ehmann, Joseph Mierski, Seema Naik, Hong Zheng, Raymond J. Hohl, Baldeep Wirk, Michelle Bernas-Peterson, Kevin Rakszawski, Emily Gerber, David F. Claxton, Matthew Bartock, Jessica Valentin, Myles Nickolich, Michele Zimmerman, Chenchen Zhao, Shin Mineishi
Publikováno v:
Transplantation and Cellular Therapy. 27:S330
Autor:
Witold B. Rybka, Michael R. Wollman, Steven M. Pincus, Elana J. Bloom, Joseph Mirro, Julie Blatt, Joseph Mierski, Albert D. Donnenberg, John W Wilson, M deMagalhaes-Silverman, M. Koehler, John Lister, Seth J. Corey, Edward D. Ball, Steven Neudorf
Publikováno v:
Journal of Hematotherapy. 6:351-359
Transplantation of marrow from unrelated donors is associated with an increased incidence and severity of graft-versus-host disease (GVHD). In an attempt to minimize GVHD without compromising engraftment, unrelated donor marrow was depleted of lympho
Autor:
Junjia Zhu, K Lucas, Joseph Mierski, Kamal Kant Singh Abbi, Giampaolo Talamo, M Carraher, David F. Claxton, Elliot E Epner, Witold B. Rybka, W. C. Ehmann
Publikováno v:
Bone marrow transplantation. 48(3)
There is little data comparing the activity and toxicity of donor lymphocyte therapy with granulocyte (G)-CSF-mobilized cells (G-donor lymphocyte infusion (DLI)) with the conventionally collected DLI (C-DLI) after allogeneic blood or marrow transplan